Sampre Nutritions logo

Sampre Nutritions MD, chairman, board of directors and AGM

BSE: 530617Food ProductsSmall Cap

Last close ₹4.98up ₹0.18 (3.75%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹4.80.

52-week range of traded prices to 23 Oct 2026
₹4.51Low, 4 Aug 2026₹42.33High, 27 Oct 2025
Market cap
₹47 Cr2,524th largest listed
P/E
Earlier quarters restated in the year
P/B
0.4
Dividend yield
Nonein the last 12 months
ROCE
2.6%
Debt to equity
0.17
Volume, BSE
1,44,064

Sampre Nutritions board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.

  • Chairperson and managing directorBrahma Gurbani

6 directors3 independent2 executive1 non-executive

  • Brahma Gurbani · Chairperson and managing directorExecutive · joined Oct 1992 · 1 listed board
  • Vishal Ratan GurbaniExecutive · joined Aug 2017 · 1 listed board
  • Vanita KhatterIndependent · joined Nov 2024 · 60 months as independent · 1 listed board · 1 as independent · 2 committee seats
  • Nagaraju KannegantiIndependent · joined Nov 2024 · 60 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
  • Kireet ModiIndependent · joined Nov 2024 · 60 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
  • Pradeep Narendra PoddarNon-executive · joined Feb 2026 · 3 listed boards · 2 as independent · 2 committee seats

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

1 director who left
  • Vinay Kumar Verma, left 19 Aug 2025: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 29 May 20266 of 6 present6 independent · 104 days in between
    • 13 Feb 2026
  • Audit Committee

    Chair Nagaraju Kanneganti

    Vanita Khatter, Kireet Modi

    • 29 May 20263 of 3 present3 independent · 104 days in between
    • 13 Feb 20263 of 3 present3 independent
  • Nomination and remuneration committee

    Chair Vanita Khatter

    Nagaraju Kanneganti, Kireet Modi

    • 13 Feb 20263 of 3 present3 independent
  • Stakeholders Relationship Committee

    Chair Kireet Modi

    Nagaraju Kanneganti, Vanita Khatter

    • 13 Feb 20263 of 3 present3 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • N G Rao & AssociatesPeer-review certificate valid to Mar 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Sampre Nutritions AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Sampre Nutritions share news and announcements

Annual general meeting, 4 Sep 2026

8,338 shareholders on the register on 31 Jul 2026; present: 6 promoters and 46 others; votes counted by AKSHITA OSTWAL / AKSHITA SURANA & ASSOCIATES.The company's voting result (opens in a new tab)

  1. To Adopt the Audited Financial Statements with the Reports of the Board of Directors and the Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 14.52% · promoters 99.99% · institutions 0.00% · other public 0.56%

  2. To Reappoint Vishal Ratan Gurbani as a Director of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 14.52% · promoters 99.99% · institutions 0.00% · other public 0.56%

  3. To Approve Revision in the Remuneration Payable to Vishal Ratan Gurbani, Whole-Time Director of the Company
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.16%

    Turnout: all 14.52% · promoters 99.99% · institutions 0.00% · other public 0.56%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Fines

Reported in the filing for the quarter to Jun 2026.

  • Fine or penaltyBSE LimitedSince 15 Jun 2026

    Imposition of fine

    Delay in furnishing prior intimation about the meeting of the board of directors

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
No
The company has a risk management committee
No
The chair is related to the managing director
No
The filing has a part on fines and penalties
Yes
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

Reported for the quarter to Mar 2025. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.

RaisedAmount raisedForSet asideSpentSpent elsewhere
Preferential IssuesJun 202453.80General corporate purposes53.800.00No
₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.